Immucell Corp (ICCC): EPS (Diluted)
-$0.12
Year ended 2025-12-31
| Period ended | EPS (Diluted) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$0.12 | n/m | 2026-03-30, From 2025-01-01 |
| 2024-12-31 | -$0.26 | n/m | 2026-03-30, From 2024-01-01 |
| 2023-12-31 | -$0.75 | n/m | 2025-03-28, From 2023-01-01 |
| 2022-12-31 | -$0.32 | n/m | 2024-04-01, From 2022-01-01 |
| 2021-12-31 | -$0.01 | n/m | 2023-03-29, From 2021-01-01 |
| 2020-12-31 | -$0.14 | n/m | 2022-03-30, From 2020-01-01 |
| 2019-12-31 | -$0.19 | n/m | 2021-03-30, From 2019-01-01 |
| 2018-12-31 | -$0.42 | n/m | 2020-03-27, From 2018-01-01 |
| 2017-12-31 | -$0.03 | n/m | 2019-03-22, From 2017-01-01 |
| 2016-12-31 | $0.12 | -68.4% | 2018-03-29, From 2016-01-01 |
| 2015-12-31 | $0.38 | n/m | 2017-03-30, From 2015-01-01 |
| 2014-12-31 | -$0.06 | n/m | 2016-03-25, From 2014-01-01 |
| 2013-12-31 | $0.04 | +33.3% | 2016-03-25, From 2013-01-01 |
| 2012-12-31 | $0.03 | n/m | 2015-03-26, From 2012-01-01 |
| 2011-12-31 | -$0.14 | n/m | 2014-03-26, From 2011-01-01 |
| 2010-12-31 | -$0.13 | n/m | 2013-03-28, From 2010-01-01 |
| 2009-12-31 | -$0.07 | n/a | 2012-03-27, From 2009-01-01 |
EPS (Diluted) at similar companies
| Company | Year ended | EPS (Diluted) | Change YoY |
|---|---|---|---|
| Immucell Corp (ICCC) | 2025-12-31 | -$0.12 | n/m |
| Alpha Teknova, Inc. (TKNO) | 2025-12-31 | -$0.32 | n/m |
| Intellia Therapeutics, Inc. (NTLA) | 2025-12-31 | -$3.81 | n/m |
| Aspira Women's Health Inc. (AWHL) | 2025-12-31 | -$0.37 | n/m |
| Anbio Biotechnology (NNNN) | 2025-12-31 | $0.15 | +162.5% |
| Biomerica Inc (BMRA) | 2026-05-31 | -$1.30 | n/m |
| Insight Molecular Diagnostics Inc. (IMDX) | 2025-12-31 | -$1.65 | n/m |
| Volitionrx Ltd (VNRX) | 2024-12-31 | -$0.31 | n/m |
| Celldex Therapeutics, Inc. (CLDX) | 2025-12-31 | -$3.90 | n/m |
Compare ICCC, TKNO, NTLA, AWHL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗